FOA-NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed); February 5, 2021

 

Agency:

NIH

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

 

Description:

This FOA invites applications for investigator-initiated, high-risk multi-center observational studies involving more than one clinical center. Proposed studies should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this FOA. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-21-101). Consultation with NIDDK Scientific/Research staff is strongly encouraged prior to the submission of either a U34 or U01 application.

 

Activity Code:

U01

 

Announcement Number:

PAR-21-103

 

Closing Dates:

February 5, 2021; June 5, 2021; October 5, 2021;

February 5, 2022; June 5, 2022; October 5, 2022;

February 5, 2023; June 5, 2023; October 5, 2023;

 

Link to Full Announcement:

http://grants.nih.gov/grants/guide/pa-files/PAR-21-103.html

 

Companion Funding Announcements:

NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)

PAR-21-102: NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required) (nih.gov)

 

NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) – PAR-21-101